Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FPV-CV301 |
Trade Name | |
Synonyms | FPV-CV-301|FPV Vaccine CV301|FPV CV301|FPV CV 301 |
Drug Descriptions |
FPV-CV301 is a booster cancer vaccine derived from recombinant fowlpox virus encoding CEA and MUC-1, as well as B7-1, ICAM-1, and LFA-3 costimulatory molecules (TRICOM), which potentially induces cytotoxic T-cell response against tumor cells expressing CEA and MUC-1 (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C141298 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bintrafusp alfa + FPV-CV301 + MVA-BN-CV301 + SX-682 | Bintrafusp alfa FPV-CV301 MVA-BN-CV301 SX-682 | 0 | 1 |
FPV-CV301 | FPV-CV301 | 0 | 0 |